NCT01215955 Study of Insulin Lispro in Participants With Inadequately Controlled Type 2 Diabetes Status COMPLETED Phase PHASE4
NCT01215942 An Open Label Study for Participants With Rheumatoid Arthritis Status TERMINATED Phase PHASE3
NCT01215097 Efficacy and Safety Study of Linagliptin (5 mg Administered Orally Once Daily) Over 24 Weeks in Type 2 Diabetic Patients With Insufficient Glycaemic Control Despite Metformin Therapy Status COMPLETED Phase PHASE3
NCT01214668 Dose-Escalation Study of LY573636-sodium and Liposomal Doxorubicin in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT01214239 Efficacy and Safety Study of Linagliptin (5 mg Administered Orally Once Daily) Over 24 Weeks, in Drug naïve or Previously Treated Type 2 Diabetic Patients With Insufficient Glycaemic Control Status COMPLETED Phase PHASE3
NCT01212107 A Phase 1 Study of LY2874455 in Participants With Advanced Cancer Status COMPLETED Phase PHASE1
NCT01210001 Efficacy and Safety of Empagliflozin (BI 10773) in Type 2 Diabetes Patients on a Background of Pioglitazone Alone or With Metformin Status COMPLETED Phase PHASE3
NCT01209832 A Tasisulam and Midazolam Drug Interaction Study in Cancer Patients Status TERMINATED Phase PHASE1
NCT01205438 A Study of LY2127399 in Participants With Systemic Lupus Erythematosus Status COMPLETED Phase PHASE3